Stockscreener 앱 받기
15.77
5.63%
0.84
시간 외 거래:
15.77
전일 마감가:
$14.93
열려 있는:
$15.26
하루 거래량:
136.57K
Relative Volume:
1.60
시가총액:
$302.01M
수익:
-
순이익/손실:
-
주가수익비율:
-0.5264
EPS:
-29.96
순현금흐름:
-
1주 성능:
+30.33%
1개월 성능:
+1,152%
6개월 성능:
+1,152%
1년 성능:
+1,152%
1일 변동 폭
$14.59
$15.97
1주일 범위
$11.91
$15.97
52주 변동 폭
$11.75
$17.94
Shoulder Innovations Inc Stock (SI) Company Profile
SI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SI
Shoulder Innovations Inc
|
15.77 | 302.01M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
131.46 | 229.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.87 | 157.64B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
393.15 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.05 | 118.26B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.90 | 47.71B | 5.69B | 1.41B | 577.90M | 6.95 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-03-06 | 다운그레이드 | Compass Point | Neutral → Sell |
| 2023-03-06 | 다운그레이드 | Wedbush | Neutral → Underperform |
| 2023-03-02 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-03-02 | 다운그레이드 | Compass Point | Buy → Neutral |
| 2023-03-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-03-01 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2023-01-09 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2023-01-06 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-01-06 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2023-01-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-12 | 재확인 | Wedbush | Outperform |
| 2022-12-05 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-11-10 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-10-26 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-10-06 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2022-08-04 | 개시 | BTIG Research | Buy |
| 2022-06-13 | 개시 | Wells Fargo | Overweight |
| 2022-06-09 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-03-21 | 개시 | BofA Securities | Buy |
| 2022-01-20 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-12-16 | 개시 | B. Riley Securities | Buy |
| 2021-11-11 | 개시 | JP Morgan | Overweight |
| 2021-11-08 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-09-27 | 개시 | Morgan Stanley | Overweight |
| 2021-06-14 | 개시 | Goldman | Neutral |
| 2021-01-14 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-12-22 | 개시 | Wedbush | Outperform |
| 2020-12-17 | 업그레이드 | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-12-02 | 개시 | Craig Hallum | Buy |
| 2020-10-16 | 개시 | Compass Point | Buy |
| 2020-03-16 | 개시 | Canaccord Genuity | Buy |
| 2019-12-03 | 개시 | Keefe Bruyette | Mkt Perform |
| 2019-12-02 | 개시 | Barclays | Overweight |
| 2019-11-18 | 개시 | Compass Point | Buy |
모두보기
Shoulder Innovations Inc 주식(SI)의 최신 뉴스
Shoulder Innovations initiated with an Overweight at Piper Sandler - MSN
Shoulder Innovations initiated with a Buy at Jefferies - MSN
Shoulder Innovations (NYSE:SI) Coverage Initiated by Analysts at Jefferies Financial Group - Defense World
Shoulder Innovations initiated with a Buy at Goldman Sachs - MSN
Strong Buy Rating for Shoulder Innovations, Inc. Driven by Market Leadership and High Growth Potential - TipRanks
Shoulder Innovations stock initiated with Overweight rating at Morgan Stanley By Investing.com - Investing.com Canada
Buy Rating for Shoulder Innovations, Inc.: Strong Growth Potential in Shoulder Replacement Market - TipRanks
Heartflow, Inc. shares rise 4.03% intraday after Goldman Sachs and Morgan Stanley initiate coverage on Shoulder Innovations. - AInvest
Piper Sandler initiates coverage on Shoulder Innovations with Overweight rating, PT $18. - AInvest
Jefferies Initiates Shoulder Innovations at Buy With $19 Price Target - MarketScreener
Goldman Sachs Initiates Shoulder Innovations at Buy With $20 Price Target - MarketScreener
Jefferies initiates Shoulder Innovations stock with Buy rating on market share gains - Investing.com Canada
Piper Sandler initiates Shoulder Innovations stock with Overweight rating By Investing.com - Investing.com Canada
Goldman Sachs initiates coverage on Shoulder Innovations stock with Buy rating - Investing.com Canada
Shoulder Innovations Expands Surgical Solutions with NYSE Listing—Global Brain Invests - thebridge.jp
Med-tech funding rebounds modestly to $18B through July - BioWorld MedTech
Medical Tech Firm Heartflow Jumps 51% After $317 Million IPO - Bloomberg.com
Medical Tech Firm Heartflow Surges 66% After $317 Million IPO - Bloomberg.com
Heartflow raises USD 317M in IPO - Medical Buyer
Medical Tech Firm Heartflow Prices $317 Million IPO Above Range - Bloomberg.com
Shoulder Innovations Stock Jumps 8% On NYSE Debut - MSN
Medical Tech Firm Heartflow Raises IPO Target to $300 Million - Bloomberg.com
Gilde healthcare buys $1.5 million in shoulder innovations (SI) By Investing.com - Investing.com UK
Gilde healthcare buys $1.5 million in shoulder innovations (SI) - Investing.com
Major Stakeholders Make Bold Moves in Shoulder Innovations, Inc. - TipRanks
Shoulder Innovations (NYSE:SI) Reaches New 52-Week HighHere's Why - MarketBeat
U.S. IPO Weekly Recap: Figma Smashes Circle’s Record For Best Billion-Dollar IPO Pop - Seeking Alpha
Heartflow prices IPO, Shoulder Innovation joins NYSE - BioWorld MedTech
Shoulder Innovations: Interesting, Not Convinced (NYSE:SI) - Seeking Alpha
Shoulder Innovations falls short of IPO target with $75M raise - Crain's Grand Rapids Business
Shoulder Innovations, Inc. shares fall 6.25% premarket as tech giants' earnings reports and Figma's IPO overshadow the market. - AInvest
NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO - The Malaysian Reserve
Latham & Watkins Advises Shoulder Innovations in Initial Public Offering - Latham & Watkins LLP
Shoulder Innovations announces pricing of IPO - Medical Buyer
Figma Surges in IPO, Valued at Over $19 Billion - AInvest
NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO – Company Announcement - Financial Times
Shoulder Innovations Announces Pricing of Initial Public Offering - PR Newswire
Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - MSN
Shoulder Innovations is an IPO to watch, this analyst says - Cantech Letter
Grand Rapids device maker plans $105M IPO as implant sales surge - Crain's Grand Rapids Business
Shoulder Innovations prices IPO at $15 per share - MarketScreener
Del. Judge Denies $89M Claim In Silvergate Ch. 11 - Law360
US Life Sciences IPOs Revive with Medtech Companies Leading the Way - AInvest
Shoulder Innovations, Inc. (SI): Small MedTech Implant Company Gaining IPO Interest - Smartkarma
These innovations are transforming shoulder replacement surgery for optimal recovery. - thegazette.com
Shoulder Innovations IPO (SI.US): Expect Upside Vs. IPO Price Due To Superior Growth Profile - Smartkarma
SHOULDER INNOVATIONS, INC. Plans $100 Million IPO for July 31st (SI) - Defense World
Pro Deals: 👩⚕️ Health Tech weekly - Axios
Shoulder Innovations Primes $100M IPO Amid Medtech Surge - Law360
Shoulder Innovations, Inc. (SI): Another MedTech to Test the Market, Sets Terms for July 31 IPO - Smartkarma
Shoulder Innovations Seeks $105M in U.S. IPO, Revenue Up 40% - AInvest
Shoulder Innovations Inc (SI) 재무 분석
Shoulder Innovations Inc (SI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.76%
0.43%
자본화:
|
볼륨(24시간):